Haplotype analysis of familial amyloidotic polyneuropathy. Evidence for multiple origins of the Val----Met mutation most common to the disease
- PMID: 2714785
- DOI: 10.1007/BF00288262
Haplotype analysis of familial amyloidotic polyneuropathy. Evidence for multiple origins of the Val----Met mutation most common to the disease
Abstract
Familial amyloidotic polyneuropathy (FAP) is an autosomal dominant genetic disease characterized by systemic accumulation of amyloid fibrils. A major component of FAP amyloid has been identified as variant transthyretin (TTR, also called prealbumin). In particular, a variant with the substitution 30Val----Met has been commonly found in FAP of various ethnic groups. To understand the origin and spread of the Val----Met mutation, we analyzed DNA polymorphisms associated with the TTR gene in six Japanese FAP families and several Portuguese FAP patients. Three distinct haplotypes associated with the Val----Met mutation were identified in Japanese FAP families, one of which was also found in Portuguese patients. On the other hand, it was found that the Val----Met mutation can be explained by a C-T transition at the CpG dinucleotide sequence of a mutation hot spot. Thus, our findings indicate that the Val----Met mutation has probably recurred in the human population, to generate FAP families of independent origin.
Similar articles
-
Genetic analysis of familial amyloidotic polyneuropathy, an autosomal dominant disease.Clin Chim Acta. 1989 Dec 15;185(3):291-7. doi: 10.1016/0009-8981(89)90219-2. Clin Chim Acta. 1989. PMID: 2559819
-
Homozygosity for the transthyretin-met30-gene in two Swedish sibs with familial amyloidotic polyneuropathy.Clin Genet. 1988 Nov;34(5):333-8. doi: 10.1111/j.1399-0004.1988.tb02887.x. Clin Genet. 1988. PMID: 3229002
-
Human transthyretin (prealbumin) gene and molecular genetics of familial amyloidotic polyneuropathy.Mol Biol Med. 1989 Apr;6(2):161-8. Mol Biol Med. 1989. PMID: 2693890 Review.
-
Structure of the mutant prealbumin gene responsible for familial amyloidotic polyneuropathy.Mol Biol Med. 1986 Aug;3(4):319-28. Mol Biol Med. 1986. PMID: 3022107
-
[Clinical and genetic heterogeneity in familial amyloidotic polyneuropathy associated with variant transthyretin].Nihon Rinsho. 1993 Sep;51(9):2435-9. Nihon Rinsho. 1993. PMID: 8411724 Review. Japanese.
Cited by
-
Transthyretin Pro 36 associated with familial amyloidotic polyneuropathy in an Ashkenazic Jewish kindred.Hum Genet. 1992 Sep-Oct;90(1-2):158-60. doi: 10.1007/BF00210764. Hum Genet. 1992. PMID: 1358785
-
Transthyretin Ser 6 gene frequency in individuals without amyloidosis.Hum Genet. 1995 Mar;95(3):308-12. doi: 10.1007/BF00225199. Hum Genet. 1995. PMID: 7868124
-
Evaluation of tafamidis as first-line therapeutic agent for transthyretin familial amyloidotic polyneuropathy.Degener Neurol Neuromuscul Dis. 2012 Oct 19;2:165-173. doi: 10.2147/DNND.S24624. eCollection 2012. Degener Neurol Neuromuscul Dis. 2012. PMID: 30890886 Free PMC article. Review.
-
Familial amyloid polyneuropathy (TTR ala 60) in north west Ireland: a clinical, genetic, and epidemiological study.J Neurol Neurosurg Psychiatry. 1995 Jul;59(1):45-9. doi: 10.1136/jnnp.59.1.45. J Neurol Neurosurg Psychiatry. 1995. PMID: 7608709 Free PMC article.
-
Prenatal diagnosis of familial amyloidotic polyneuropathy: evidence for an early expression of the associated transthyretin methionine 30.Hum Genet. 1990 Oct;85(6):623-6. doi: 10.1007/BF00193586. Hum Genet. 1990. PMID: 1977686
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous